Enfermedades osteocondensantes con compromiso de huesos largos: presentación de dos casos y revisión de la literatura

de Vernejoul, 2010, Heritable sclerosing bone disorders: presentation and new molecular mechanisms, Ann N Y Acad Sci, 1192, 269, 10.1111/j.1749-6632.2009.05244.x Mejía-Vallejo, 2009, Enfermedades osteocondensantes: una nueva visión clínico-radiológica soportada en la genética y la inmunoosteología, Revista Colombiana de Reumatología, 16, 46, 10.1016/S0121-8123(09)70118-5 Toro, 2007, Osteoesclerosis axiales Propuesta para una nueva aproximación diagnóstica, Revista Colombiana de Reumatología, 14, 44 Bénichou, 2000, Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients, Bone, 26, 87, 10.1016/S8756-3282(99)00244-6 Bollerslev, 1989, Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical, and hormonal aspects, Endocr Rev, 10, 45, 10.1210/edrv-10-1-45 Granados Sandoval, 2007, Osteopetrosis (enfermedad de Albers-Schonberg): reporte de un caso y revisión clínica, Med Int Mex, 23, 542 Benavente, 2011, reporte de un caso en paciente de 20 años, Rev. Chil. Reumatol, 27, 25 Bollerslev, 1998, Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis, Bone, 91, 7 Quintana, 2004, Osteomesopicnosis asociada a litiasis renal Informe de un caso. Diagnóstico diferencial de las enfermedades osteoesclerosantes axiales, Revista Colombiana de Reumatología, 11, 341 Bollerslev, 1987, Osteopetrosis. A genetic and epidemiological study, Clin Genet, 31, 86, 10.1111/j.1399-0004.1987.tb02774.x Waguespack, 2007, Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation, J Clin Endocrinol Metab, 92, 771, 10.1210/jc.2006-1986 Kaste, 2007, Quantitative bone mineral density assessment in malignant infantile osteopetrosis, Pediatr Blood Cancer, 48, 181, 10.1002/pbc.20759 Iglesias, 1988, Hiperostosis cortical generalizada Presentación de cuatro casos. Descripción de una nueva variante, Salud Uninorte, 4-5, 181 Hernández-Cassis, 2003, Autosomal dominant hyperostosis/osteosclerosis with high serum alkaline phosphatase activity, J Clin Endocrinol Metab, 88, 2650, 10.1210/jc.2001-011428 de Vernejoul, 2008, Sclerosing bone disorders, Best Pract Res Clin Rheumatol, 22, 71, 10.1016/j.berh.2007.12.011 1998, International Nomenclature and Classification of the Osteochondrodysplasias. 1997, Am J Med Genet, 79, 376 Whyte, 1996, Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteopetroses among the sclerosing bone disorders, J Bone Miner Res, 11, 1438, 10.1002/jbmr.5650111010 Frattini, 2000, Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis, Nature Genetics, 25, 343, 10.1038/77131 Frattini, 2003, Chloride channel ClCN7mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis, The Journal of Bone and Mineral Research, 18, 1740, 10.1359/jbmr.2003.18.10.1740 Van Hul, 2000, Autosomal dominant osteopetrosis type I is genetically linked to the same region on human chromosome 11 as the high bone mass phenotype, J Bone Miner Res, 15, S260 Van Hul, 1997, Localization of a gene for autosomal dominant osteopetrosis Albers-Schonberg disease to chromosome 1p21, Am J Hum Genet, 61, 363, 10.1086/514844 Gelb, 1996, Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency, Science, 273, 1236, 10.1126/science.273.5279.1236 Maroteaux, 1962, La pycnodysostose, Presse Med, 70, 999 Jacobson, 1985, Dense bone—too much bone: Radiological considerations and differential diagnosis (parts I and II), Skeletal Radiol, 13, 97, 10.1007/BF00352080 Edelson, 1992, Pycnodysostosis: Orthopedic aspects, with a description of 14 new cases, Clin Orthop, 280, 263, 10.1097/00003086-199207000-00037 Janssens, 2003, Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein, J Biol Chem, 278, 7718, 10.1074/jbc.M208857200 Janssens, 2006, Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment, Journal of Medical Genetics, 43, 1 Vanhoenacker, 2000, Sclerosing bone dysplasias: genetic and radioclinical features, Eur Radiol, 10, 1423, 10.1007/s003300000495 Hellemans, 2004, Loss-of-function mutations in LEMD3 result in osteopoikilosis Buschke- Ollendorff syndrome and melorheostosis, Nat. Genet, 36, 1213, 10.1038/ng1453 Krishnan, 2006, Regulation of bone mass by Wnt signaling, The Journal of Clinical Investigation., 116, 1202, 10.1172/JCI28551 Balemans, 2002, Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease, J Med Genet, 39, 91, 10.1136/jmg.39.2.91 Brunkow, 2001, Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein, Am J Hum Genet, 68, 577, 10.1086/318811 Krishnan, 2006, Regulation of bone mass by Wnt signaling, J Clin Invest, 116, 1202, 10.1172/JCI28551 Hamersma, 2003, The natural history of sclerosteosis, Clin Genet, 63, 192, 10.1034/j.1399-0004.2003.00036.x Boyden, 2002, High bone density due to a mutation in LDL-receptor-related protein 5, The New England Journal of Medicine, 346, 1513, 10.1056/NEJMoa013444 Little, 2002, A mutation in the LDL receptorrelated protein 5 gene results in the autosomal dominant high-bone-mass trait, American Journal of Human Genetics, 70, 11, 10.1086/338450